{"id":3579,"date":"2026-06-02T18:16:26","date_gmt":"2026-06-02T18:16:26","guid":{"rendered":"https:\/\/indiamedicine.org\/?p=3579"},"modified":"2026-06-02T18:16:26","modified_gmt":"2026-06-02T18:16:26","slug":"who-gmp-certification-indian-generics-schedule-m-rules","status":"publish","type":"post","link":"https:\/\/indiamedicine.org\/?p=3579","title":{"rendered":"WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">&#x1f52c; WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You<\/h1>\n\n\n\n<p class=\"wp-block-paragraph\">India supplies approximately <strong>20% of the world&#8217;s generic medicines by volume<\/strong>, making it the largest provider of affordable generic drugs globally. But with this scale comes a critical question for buyers around the world: <strong>How do you know if an Indian generic medicine is safe, effective, and manufactured to international quality standards?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The answer lies in <strong>WHO-GMP certification<\/strong> and India&#8217;s newly revised <strong>Schedule M<\/strong> manufacturing standards \u2014 the most significant overhaul of Indian pharmaceutical quality regulations in decades. This article explains what these standards mean for you as a buyer or patient.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f3ed; What Is WHO-GMP Certification?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Good Manufacturing Practices (GMP)<\/strong> are the minimum quality standards that pharmaceutical manufacturers must meet to ensure their products are consistently produced and controlled according to quality standards. <strong>WHO-GMP certification<\/strong> means a facility has been audited by or complies with standards set by the World Health Organization.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>WHO-GMP covers: <strong>raw materials, facility hygiene, equipment calibration, staff training, documentation, and quality control testing<\/strong><\/li>\n<li>It is <strong>recognized globally<\/strong> \u2014 including by the FDA (US), EMA (Europe), and other national regulators<\/li>\n<li>Indian manufacturers with WHO-GMP certification can export to <strong>over 150 countries<\/strong><\/li>\n<li>Without WHO-GMP compliance, a generic medicine cannot be sold in most regulated markets<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">As reported by ClearIAS (March 2026) and The Economic Times, India&#8217;s position as the largest generic medicine provider makes adherence to WHO-GMP standards a matter of <strong>global public health importance<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f1ee;&#x1f1f3; India&#8217;s New Schedule M: The Biggest Quality Overhaul Since 1988<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Schedule M<\/strong> is the section of India&#8217;s Drugs and Cosmetics Rules that lays out GMP requirements for pharmaceutical manufacturers. In 2025-2026, the Indian government implemented the <strong>most significant revision of Schedule M<\/strong> in nearly four decades, bringing Indian standards more closely in line with WHO-GMP and international benchmarks.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">&#x1f4cb; Key Changes in the Revised Schedule M<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Phased rollout timeline<\/strong>: Large manufacturers must comply by mid-2026; small and medium enterprises (MSMEs) have been granted an extension until later in 2026\u20132027 (KNN India, December 2025)<\/li>\n<li><strong>Mandatory bioequivalence (BE) studies<\/strong>: For certain dosage forms, manufacturers must now submit BE data \u2014 a first for Indian domestic regulation<\/li>\n<li><strong>Enhanced quality management systems<\/strong>: Documentation standards now aligned with ICH Q10 guidelines<\/li>\n<li><strong>Stricter water and air handling systems<\/strong>: ISO-classified clean rooms required for sterile manufacturing<\/li>\n<li><strong>CDSCO outsourcing GMP audits<\/strong>: The Drugs Controller General of India (DCGI) has instructed state regulators to enforce the new standards, with an expert cadre of approximately 1,500 scientific personnel being built (IndiaMedToday, February 2026)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">As reported by Express Pharma and GlobalData (October 2025), the new GMP standards have created some tension between regulators and smaller manufacturers \u2014 but the overall direction is toward <strong>higher quality and greater global trust<\/strong> in Indian generics.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f50d; How to Verify If a Generic Medicine Is WHO-GMP Compliant<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">As a buyer or patient, here is a practical checklist to verify the quality of Indian generic medicines before purchasing:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Check the product packaging<\/strong> \u2014 Look for the WHO-GMP logo or a statement like &#8220;Manufactured in a WHO-GMP certified facility&#8221; on the label or carton<\/li>\n<li><strong>Verify the manufacturer on CDSCO&#8217;s website<\/strong> \u2014 The Central Drugs Standard Control Organization maintains a public database of licensed manufacturers. Visit <code>cdsco.gov.in<\/code> and check the manufacturer&#8217;s license number<\/li>\n<li><strong>Ask for the batch analysis certificate<\/strong> \u2014 Reputable manufacturers provide a Certificate of Analysis (CoA) for each batch, which includes purity, potency, and dissolution test results<\/li>\n<li><strong>Check if the manufacturer is on WHO&#8217;s prequalification list<\/strong> \u2014 The WHO maintains a list of prequalified manufacturers and products at <code>extranet.who.int\/pqweb<\/code><\/li>\n<li><strong>Look for third-party auditor reports<\/strong> \u2014 Many WHO-GMP certified facilities are audited by international bodies like the <strong>WHO, PIC\/S, or national regulatory agencies<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">For a list of verified and reliable pharmaceutical distributors, refer to the <a href=\"https:\/\/indiamedicine.org\/?page_id=1454\">IMSDA&#8217;s verified member directory<\/a>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f30d; Why WHO-GMP Matters for Global Buyers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">For international buyers importing Indian generics \u2014 particularly from the United States, Europe, Africa, and Southeast Asia \u2014 WHO-GMP certification is more than a label. It is often a <strong>regulatory requirement<\/strong> for import clearance.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>US FDA<\/strong>: Requires that generic drug manufacturers pass FDA inspections or demonstrate mutual recognition with WHO-GMP equivalence. India has one of the highest numbers of FDA-registered manufacturing facilities outside the US<\/li>\n<li><strong>European EMA<\/strong>: Accepts WHO-GMP certification as part of the marketing authorization process for generic drugs sourced from India<\/li>\n<li><strong>WHO Prequalification<\/strong>: Essential for generic medicines supplied to UN agencies, NGOs, and developing-nation health programs \u2014 requires WHO-GMP as a baseline<\/li>\n<li><strong>African and ASEAN regulators<\/strong>: Many now accept WHO-GMP certification in lieu of domestic inspections, streamlining the import process<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x2705; Practical Takeaways for Patients and Buyers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">To summarize, here is what every buyer of Indian generic medicines should know:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>&#x2705; <strong>India supplies 20% of the world&#8217;s generic medicines<\/strong> \u2014 scale does not compromise quality under the new Schedule M regime<\/li>\n<li>&#x2705; <strong>Revised Schedule M (2025-2026)<\/strong> brings Indian GMP standards fully in line with international WHO-GMP norms<\/li>\n<li>&#x2705; <strong>WHO-GMP certified facilities<\/strong> are audited regularly by internal and external inspectors<\/li>\n<li>&#x2705; <strong>CDSCO reforms<\/strong> are building a stronger inspection system with 1,500+ expert personnel<\/li>\n<li>&#x2705; <strong>Bioequivalence requirements<\/strong> for key drug categories ensure generics are therapeutically equivalent to branded counterparts<\/li>\n<li>&#x2705; <strong>Verified distributors<\/strong> can help you source from WHO-GMP compliant manufacturers<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">&#x2695;&#xfe0f; <strong>Your health depends on the quality of the medicines you take<\/strong>. By understanding WHO-GMP standards and how to verify compliance, you can make informed decisions and access safe, affordable, and effective generic medicines from India.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">For more information, contact IMSDA at <a href=\"mailto:contact@indiamedicine.org\">contact@indiamedicine.org<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Sources: ClearIAS (March 2026), IndiaMedToday (February 2026), KNN India (December 2025), Express Pharma\/GlobalData (October 2025), CDSCO official guidelines, WHO Prequalification Program.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#x1f52c; WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You India supplies approximately 20% of the world&#8217;s generic medicines by volume, making it the largest provider of affordable generic drugs globally. But with this scale comes a critical question for buyers around the world: How do you know if an [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[42,41,48,29,44],"class_list":["post-3579","post","type-post","status-publish","format-standard","hentry","category-knowledge","tag-cdsco","tag-fda","tag-generic-medicines","tag-india-pharmacy","tag-who","entry"],"_links":{"self":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3579"}],"version-history":[{"count":0,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3579\/revisions"}],"wp:attachment":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}